Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] Samsung SDI (006400) – Mirae Asset Securities | Commencing Customer T ESS Business (Estimated) · SDC Asset Utilization · Valuation Gap Narrowing / 2026-02-03 Research
  • [Research] Samsung SDI (006400) – Mirae Asset Securities | SDC Stake Monetization · Tesla ESS Business Expansion · Earnings Trough / 2026-02-20 Research
  • [IR] Samsung Electronics (005930) – Q4 2024 Earnings Presentation / 2025-01-31 IR Room
  • [Research] SK hynix (000660 / SKHY) – Hyundai Motor | Agentic AI · Memory Demand · Cycle Stability / 2026-05-13 Research
  • [Research] Celltrion (068270) – Shinhan Securities | New Product Sales Expansion · Operating Leverage · Global CMO Contracts / 2026-05-15 Research
  • [Research] SK hynix (000660 / SKHY) – Daishin | ADR Listing · HBM4 · Valuation Re-rating / 2026-07-07 Research
  • [Research] Samsung SDI (006400) – Hana Securities | North America JV Resolution · ESS Line Conversion · Earnings Estimate Upgrades / 2026-08-12 Research
  • [Research] LIG D&A (079550) – DS Investment & Securities | Order Expansion · Iraq Cheongung-II Mass Production · Long-term Earnings Growth / 2026-08-07 Research

[Research] SK hynix (000660 / SKHY) – Hana | Memory Pricing · Long-Term Contracts · HBM4 / 2026-01-14

Posted on January 14, 2026August 24, 2026 By ksb220805@gmail.com

Market: KOSPI (000660)

Brokerage : Hana Securities

Analyst : Rok-Ho Kim (RA: Myeonggyu Kim)

Investment Rating : BUY (Maintained)

Target Price : 1,120,000 KRW (Raised)

Core Momentum : Intensifying memory supply shortages and robust server demand are expected to sustain DRAM and NAND price increases, while multi-year supply contracts and expanding HBM4 shipments strengthen earnings growth and mid-to-long-term visibility.

📊 1. [Valuation & Key Financial Metrics]

  • Target Price: 1,120,000 KRW (Raised from 850,000 KRW reflecting upward revisions in 2026 operating profit)
  • Investment Rating: BUY (Maintained)
  • 2026 Financial Outlook: Revenue 180.9 trillion KRW, Operating Profit 112.0 trillion KRW, Net Income 91.548 trillion KRW
  • EPS: 125,753 KRW (Based on 2026 estimates)
  • Valuation Multiples: PER 5.96x, PBR 2.65x, ROE 57.70% (Based on 2026 estimates)

🚀 2. [Market Opportunities & Business Outlook]

  • 4Q25 Preview: Revenue is expected to reach 32.6 trillion KRW (+65% YoY, +33% QoQ) and operating profit 17.0 trillion KRW (+115% YoY, +52% QoQ). QoQ memory price increases are assumed at 22% for DRAM and 28% for NAND.
  • Full-Year Outlook: Annual 2026 revenue and operating profit are projected to surge 87% and 147% YoY to 180.9 trillion KRW and 112.0 trillion KRW, respectively. Supply shortages are anticipated to persist from 4Q25 through 1Q26, leading to assumed annual price gains of 54% for DRAM and 55% for NAND.
  • Supply & Contracts: While smartphone and PC clients may adjust shipment volumes due to cost burdens, robust server-side demand is expected to offset them. Ongoing discussions regarding 2-to-3-year long-term supply contracts with major customers signal cycle prolongation and enhanced earnings visibility.
  • HBM & Investments: HBM-related revenue and operating profit estimates are seeing substantial upward revisions driven by recent memory pricing trends. HBM4 shipments are projected to account for over half of total volume in the second half, while backend packaging line expansions reinforce mid-to-long-term top-line visibility.

📝 Editor’s Comment (Perspective)

The analyst views SK hynix as an enterprise capturing steeper-than-expected memory price uptrends and intensifying supply shortages, driving full-year 2026 operating profit to 112 trillion KRW. The analyst emphasizes robust growth momentum alongside HBM valuation premiums and structural visibility secured via long-term contracts.

To verify this investment thesis, one should track whether actual 4Q25 and 1Q26 earnings meet estimates, if the annual price increase assumptions for DRAM (54%) and NAND (55%) materialize, and how long-term supply contracts and HBM4 mass production schedules unfold. These indicators can be monitored through upcoming quarterly reports and regulatory filings via DART.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

Post navigation

Previous Post: [Research] Samsung Biologics (207940) – iM Securities | Spin-off Valuation Re-rating · Biosecure Act Inflows · Plant 6 Groundbreaking / 2026-01-09
Next Post: [Research] Samsung SDI (006400) – Mirae Asset Securities | Hypothetical SDC Stake Monetization · North American ESS Acceleration · Valuation Appeal / 2026-01-19

Related Posts

  • [Research] LIG D&A (079550) – Daishin Securities | 1Q26 Review · Earnings Surprise · Export Diversification / 2026-05-08 Research
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Commodity Memory Pricing · Server Demand · Earnings Upgrades / 2026-01-30 Research
  • [Research] Samsung Electro-Mechanics (009150) – Shinhan Securities | AI MLCC · FC-BGA · ASP Increase / 2026-05-04 Research
  • [Research] Alteogen (196170) – Shinhan Securities | 2 Out-Licensing Deals in Q1 · Biogen Deal Analysis · Major Catalysts Ahead from April / 2026-03-27 Research
  • [Research] Samsung SDI (006400) – Shinhan Securities | Expanding North American ESS Momentum · Sole Non-China Prismatic Maker · 4Q In Line / 2026-02-03 Research
  • [Research] Celltrion (068270) – Daishin Securities | Merger Noise Resolution · Portfolio Expansion Leverage · CMO Revenue Visibility / 2026-05-19 Research
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | Silicon Capacitor LTA · 800VDC Infrastructure · 2027 Operating Profit 3T / 2026-05-21 Research
  • [IR] Samsung Electro-Mechanics (009150) – Q2 2024 Earnings Presentation / 2024-07-31 IR Room
  • [Research] Samsung Biologics (207940) – Daishin Securities | Peptide Market Entry · Global Footprint Expansion · Modality Diversification / 2026-07-21 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | ADR Listing · PHLX Inclusion · Valuation Re-rating / 2026-06-01 Research
  • [Research] Samsung Biologics (207940) – IBK Securities | US Operations · Plant 5 Ramp-up · Peptide Expansion / 2026-07-24 Research
  • [IR] Samsung Electronics (005930) – Q3 2024 Earnings Presentation / 2024-10-31 IR Room
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | DRAM Pricing · Big Tech Demand · Earnings Upgrades / 2026-01-19 Research
  • [Research] Alteogen (196170) – Daishin Securities | Validated ALT-B4 Platform · Keytruda SC Milestones Accelerate · Coverage Initiation / 2026-05-19 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme